
Keywords: فسفونیوزیتید-3 کیناز; AD; Alzheimer's disease; cAMP; cyclic adenosine monophosphate; CB1R; Cannabinoid receptor 1; CNS; central nervous system; co-IP; co-immunoprecipitation; Cy3; cyanine 3; D2R; dopamine receptor 2; ERK1/2; extracellular signal-regulated kinase 1/2; FITC; f